Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope-Reference-Cited by-同舟云学术

Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope

Published:2006-03 Issue:9 Volume:43 Page:1349-1357
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Norris Philip J.,Stone Jennifer D.,Anikeeva Nadezhda,Heitman John W.,Wilson Ingrid C.,Hirschkorn Dale F.,Clark Margaret J.,Moffett Howell F.,Cameron Thomas O.,Sykulev Yuri,Stern Lawrence J.,Walker Bruce D.

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference53 articles.

1. A structural basis for LCMV immune evasion: subversion of H-2D(b) and H-2K(b) presentation of gp33 revealed by comparative crystal structure. Analyses;Achour;Immunity,2002

2. T-cell-receptor affinity and thymocyte positive selection;Alam;Nature,1996

3. Functional consequences of engagement of the T cell receptor by low affinity ligands;Alexander;J. Immunol.,1993

4. Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism;Bachmann;Eur. J. Immunol.,1998

5. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling;Baker;Immunity,2000

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Nested Peptide Epitopes Recognized by CD4+ T Cells Induced by HIV-1 Conserved-Region Vaccines;Vaccines;2020-01-16

2. T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity;Expert Review of Vaccines;2016-02-15

3. On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy);International Archives of Allergy and Immunology;2016

4. Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection;Frontiers in Microbiology;2014-10-06

5. A CD4+T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function;Retrovirology;2014-07-05